Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial

BACKGROUND: Psoriasis is an immune-mediated chronic inflammatory skin disorder for which several targeted biologic therapies became available in the last 10 years. Data from patients with rheumatoid arthritis revealed that dose tapering combined with tight control of disease activity is successful....

Descripción completa

Detalles Bibliográficos
Autores principales: Atalay, Selma, van den Reek, Juul M. P. A., van Vugt, Lieke J., Otero, Marisol E., van de Kerkhof, Peter C. M., den Broeder, Alfons A., Kievit, Wietske, de Jong, Elke M. G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422943/
https://www.ncbi.nlm.nih.gov/pubmed/28482858
http://dx.doi.org/10.1186/s12895-017-0057-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422943/
https://www.ncbi.nlm.nih.gov/pubmed/28482858
http://dx.doi.org/10.1186/s12895-017-0057-6

Ejemplares similares